SCHEMBL29827269

SCHEMBL29827269

CCN(CC)c1ccc2ccccc2c1S(=O)(=O)Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAX8 Q06710 1/20 0.38
▸ ELANE P08246 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ NPC1 O15118 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HPRT1 P00492 1/20 0.35
▸ PLK1 P53350 1/20 0.35
▸ SLC40A1 Q9NP59 1/20 0.34
▸ MAPT P10636 2/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34
▸ KEAP1 Q14145 1/20 0.34
▸ NFE2L2 Q16236 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ CYP2A6 P11509 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31040674 0.84 CYP2D6 (0.40) ELANESMN1; SMN2LMNANPC1MEN1
SCHEMBL1660887 0.82 PAX8 (0.41) PAX8LMNAMEN1KMT2AHPRT1
SCHEMBL29827543 0.82 PAX8 (0.41) PAX8LMNAMEN1KMT2AHPRT1
SCHEMBL10741200 0.78 PAX8 (0.44) PAX8HPRT1SLC40A1KEAP1ALDH1A1
Acetonitrile SCHEMBL28781302 0.76 PAX8 (0.36) PAX8SMN1; SMN2LMNANPC1MEN1
SCHEMBL8584659 0.73 CYP2A6 (0.41) ELANESMN1; SMN2LMNANPC1MEN1
SCHEMBL2574159 0.73 CYP2A6 (0.50) PAX8KMT2AHPRT1MAPTKEAP1
SCHEMBL14861459 0.72 ALDH1A1 (0.46) SMN1; SMN2LMNAKMT2ARAB9AALDH1A1
SCHEMBL2203473 0.71 NPC1 (0.48) ELANESMN1; SMN2NPC1MEN1KMT2A
SCHEMBL10904256 0.71 PTPN22 (0.48) MAPTSIGMAR1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118688315-A Multichannel high-coverage synchronous quantification method for amino-containing and hydroxyl-containing compounds 复旦大学 2024-09-24 — — CN disclosed
US-20240286996-A1 NAPHTHALENESULFONYL COMPOUNDS, AND PREPARATION METHODS AND APPLICATIONS FUDAN UNIVERSITY (CN) 2024-08-29 — — US disclosed
WO-2023016517-A1 NAPHTHALENESULFONYL COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 复旦大学 2023-02-16 — — WO disclosed
CN-113620847-B Naphthalenesulfonyl compounds, preparation method and application thereof 复旦大学 2022-08-09 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240286996-A1 NAPHTHALENESULFONYL COMPOUNDS, AND PREPARATION METHODS AND APPLICATIONS ABCG2, TST, STS PAX8 4344/4885ELANE 1315/4885SMN1; SMN2 1796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback